1. Home
  2. Live Updates
  3. 89bio: Despite Peer Trial Setback, Potential Remains In NASH

89bio: Despite Peer Trial Setback, Potential Remains In NASH

89bio: Despite Peer Trial Setback, Potential Remains In NASH (NASDAQ:ETNB)

89bio: Despite Peer Trial Setback, Potential Remains In NASH (NASDAQ:ETNB)

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Advisory Committee , Development Laboratory , Akero Therapeutics Inc , Nasdaq , Madrigal Pharmaceuticals Inc , European Medicines Agency , Biotechnology Research In Advanced Pharma Lab , Medical Development Laboratory , Analyzes Petri Dish , Specialists Working , Biotechnology Research , Advanced Pharma Lab , Accelerated Approval , Akero Therapeutics , Accelerated Approvals Could Mean , Quicker Approval , Madrigal Pharmaceuticals , New Drug Application , Priority Review ,